APRaD - we stand for access for patients with rare diseases
Service and dedication bridging the latest
biotech and pharmaceutical discoveries
and those who need them most
About us
In Rare/Orphan disease space, where innovators may lack the commercial capabilities or footprint to reach broader markets, it may take from several years to a decade before patients can access often life-saving therapy. APRaD is an emerging force aiming to close this gap in markets we operate.
our mission
We set on a mission to accelerate innovative rare disease treatments to Russia & CIS countries by providing to innovators the expertise and capabilities in Market Access, Commercial, Medical, and Marketing
our offer
We offer a comprehensive set of capabilities to enable emerging biotech and pharmaceutical companies reach patients and markets in Russia and CIS countries
our motto
APRaD - bridging patients and cure
Meet APRaD founders team
vladimir averin
Vladimir brings experience leading Rare Disease units for global pharmaceuticals in Russia & CIS, sporting the most effective launches on the market
Gregory nemenov
Gregory is a MD with over 20 years of experience in Commercial Operations and Distribution function from 'big pharma'
alexander zverev
Alexander has vast experience in Market Access and building effective regional outreach for innovative products
Our capabilities
We offer a comprehensive set of capabilities to enable emerging biotech and pharmaceutical companies reach patients in the markets of Eurasian Economic Union (Kazakhstan, Russia, Belarus, Kyrgyzstan, Armenia), other CIS countries (Uzbekistan, Azerbaijan, Turkmenistan, Tajikistan, Moldova) and Georgia
Regulatory & Market Access
Early Access Programs
Medical Affairs
Patient Support Programs
Marketing & Sales
Distribution & Logistics